Philip Morris International Inc. vs Teladoc Health Inc — how do they compare? Philip Morris International Inc. trades at $195 (market cap $293.07B), while Teladoc Health Inc trades at $8.87 (market cap $1.75B). The key difference: Philip Morris International Inc. is far larger — about 167.5× Teladoc Health Inc's market cap, and Philip Morris International Inc. pays a 3.13% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| PM | TDOC | |
|---|---|---|
Market Cap | $293.07B | $1.75B |
Sector | Consumer Staples | Health |
52-Week High | $192.98 | $9.72 |
52-Week Low | $144.33 | $4.47 |
Enterprise Value | $339.57B | $2.04B |
Dividend Yield | 3.13% | — |
Signals from Pluang's Aura AI — not financial advice
Philip Morris International (PM) trades at $194.30, up 0.82% today, with strong analyst support (68% buy ratings) and a consensus price target of $194. The stock shows bullish technical momentum above key support levels, supported by robust fundamentals including 2025 revenue of $40.65B and net income of $11.35B. Recent news highlights include a $500M impairment charge and updated 2026 guidance, while the IQOS brand gained recognition as a top global brand.
PM offers stable dividend income and growth potential, but faces headwinds from cost pressures, currency volatility, and regulatory risks in tobacco markets. The current valuation at 26.47 P/E appears reasonable given earnings consistency, though investors should monitor margin trends and illicit market impacts in Europe. Near-term price action hinges on Q2 2026 earnings versus the $2.04 EPS estimate.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →